Last update:
Endocrinology news
Being obese can make you more likely to be unemployed
The effect of obesity on unemployment is more than twice as large as previously thought, finds a UK Biobank study of genetic evidence.
Jul 17, 2026
0
4
Semaglutide and other GLP-1 drugs not linked to risk of degenerative eye disease in adults with type 2 diabetes
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of medication that mimics the GLP-1 hormone—to lower blood sugar and support weight loss. Some research ...
Jul 17, 2026
0
4
Rise of GLP-1s raises long-term affordability questions
As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new Northwestern University study that analyzed national trends in GLP-1 use and spending between 2017 and 2022. ...
Jul 16, 2026
0
5
What's driving the obesity pandemic?
New research presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico, (15–17 July) asks what is driving the obesity pandemic.
Jul 16, 2026
0
13
GLP-1 receptor agonist use does not increase insulin discontinuation with type 2 diabetes
For veterans with type 2 diabetes (T2D) receiving basal insulin therapy, the addition of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) does not increase the rate of insulin discontinuation compared with other glucose-lowering ...
Jul 16, 2026
0
4
Study identifies patients with obesity most likely to benefit from GLP-1-based treatment
Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype of obesity that responds ...
Jul 16, 2026
0
5
Ozempic-like drugs have more benefits to the body than just losing weight, meta-analysis shows
A meta-analysis of 10 randomized controlled trials involving more than 23,000 participants, presented at the International Congress on Obesity (ICO 2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico ...
Jul 16, 2026
0
4
Internet searches on weight-loss medications have increased 25-fold since the launch of GLP-1 drugs
Public interest in obesity medication has risen 25-fold since the launch of GLP-1 receptor agonist drugs, new research presented at the International Congress on Obesity (ICO2026) in Mexico City, Mexico, hosted by the World ...
Jul 15, 2026
0
20
Changing behavior to aid weight loss may be linked to reduced risks of obesity related cancers
A new systematic review and meta-analysis presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico, July 15–17, is the first study to show that behavioral ...
Jul 15, 2026
0
4
Review calls for Mexico to add liver health to chronic disease programs
Liver disease may affect close to half of adults in Mexico, yet the country tracks it far less closely than the diabetes and obesity to which it is linked, according to a new paper by Jeffrey Lazarus, professor at the CUNY ...
Jul 15, 2026
0
3
Muscles matter for diabetes risk, new study finds
A major new international study led by Curtin University has found diabetes risk is about more than body weight or obesity, revealing that muscle health also likely plays a major role in whether people develop the condition.
Jul 14, 2026
0
11
One in four adults has metabolic syndrome, and it may be aging their brains
An estimated 1 in 4 adults worldwide has metabolic syndrome. While metabolic syndrome is most often thought of as a warning sign that diabetes or cardiovascular disease may be on the horizon, my team's new study suggests ...
Jul 14, 2026
0
5
Simple test could help track metabolic health in cancer and chronic disease
Researchers writing in Frontiers in Science propose using simple tests to track metabolic health in noncommunicable diseases, which cause three in four deaths worldwide.
Jul 14, 2026
0
3
Primary care initiation of continuous glucose monitoring is effective
Among adults with insulin-treated diabetes, initiation of continuous glucose monitoring (CGM) by primary care clinicians is associated with clinically meaningful improvements in hemoglobin A1c (HbA1c) and significant reductions ...
Jul 14, 2026
0
3
Preclinical study points to a promising combined strategy for slowing the progression of type 1 diabetes
An international research group led by researchers from VUB-UZ Brussels and KU Leuven has demonstrated that a combined approach targeting both the immune system and insulin-producing beta cells can slow the progression of ...
Jul 14, 2026
0
3
Hormonal changes during puberty linked to emotional distress in young girls
Testosterone may play a bigger role in the emotional development of girls entering puberty than previously thought, according to new research from the University of Georgia published in Psychoneuroendocrinology. Greater changes ...
Jul 13, 2026
0
53
Study finds obesity 'fuels' leukemia, but a combo using popular weight-loss drugs may stop it
Obesity can act as fuel for leukemia, according to a study led by Indiana University School of Medicine scientists. To help patients facing aggressive blood cancers overcome this metabolic risk, researchers identified a potential ...
Jul 13, 2026
0
6
Knowledge about genes isn't enough: How to inform people about genetic risk of obesity
Does informing people about their genetic risk of obesity help them change their habits and lose excess weight? A study published in the journal Obesity Reviews by scientists, including researchers from SWPS University, shows ...
Jul 13, 2026
0
1
Night owls eat later, choose less nutritious food, carry more belly fat and show higher metabolic risk
For generations, early to bed and early to rise was seen as the blueprint for a healthy life, and any departure from it was often considered unhealthy. Scientists, however, have discovered that whether someone is an early ...
Gene discovery may unlock infertility, early menopause clues
Most women are aware that fertility declines dramatically with age. This is mainly due to the gradual loss of eggs and follicles from the ovaries, leading to infertility, irregular cycles and ultimately menopause.
Jul 12, 2026
0
8
Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial
Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection for diabetes management, can significantly improve blood sugar levels and lead to ...
Jul 11, 2026
0
897
New first-in-human study explores immune-engineered cell therapy approach for type 1 diabetes
New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach that could expand the potential of cell replacement therapy for type 1 diabetes by evaluating whether ...
Jul 10, 2026
0
12
Weight‑loss jabs may create a new kind of yo‑yo dieting
For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped under the label GLP-1 medicines because they mimic hormones released after ...
Jul 10, 2026
0
6
Both synthetic and organic tampons found to leach hormone-disrupting chemicals, study shows
A study has found some tampons leach low levels of chemicals that disrupt hormones, regardless of whether they are synthetic or organic.
Jul 9, 2026
0
7
Researchers uncover hormone link between gut and brain in anorexia nervosa
People with anorexia nervosa have unusually high levels of a hormone called LEAP2 in their blood when they are in the acute phase of the disorder, according to research presented at the Federation of European Neuroscience ...
Jul 9, 2026
0
4
